Talphera, Inc. (TLPH)
Nasdaq: TLPH · Pharmaceutical Preparations · San Mateo, CA · filing with the SEC since 2008
Who owns Talphera, Inc.
As filed with the SECHolders of 5% or more
5
CorMedix Inc. holds 19.9% of Common Stock, as its SCHEDULE 13D filed Sep 12, 2025 says.
Directors and officers
11
report now, of 20 people on the record since 2011. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
CorMedix Inc.
SCHEDULE 13D · filed Sep 12, 2025 · Common Stock
Nantahala Capital Management, LLC
SCHEDULE 13D/A · filed Apr 3, 2025 · Common Stock, par value $0.001 per share · 11.7% in Apr 2, 2025
Rosalind Advisors, Inc.
SCHEDULE 13G/A · filed Aug 12, 2026 · Common Shares · 9.9% in May 12, 2026
Orin Hirschman
SCHEDULE 13G/A · filed Jan 30, 2026 · Common Stock, $0.001 par value · 9.7% in Nov 10, 2025
Rock Springs Capital Management LP
SCHEDULE 13G · filed Sep 12, 2025 · Common Stock, $0.001 par value
Lytton Laurence W
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock · reported falling below 5%, from 5.9% in Feb 17, 2026
What TLPH reports owning in othersstakes of 5% or more, and other ties
Talphera, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
5purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$300,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 32 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Angotti Vincent J. | CHIEF EXECUTIVE OFFICER | 0 | $0 | 0 | 2 | $200,000 |
| Asadorian Raffi | Chief Financial Officer | 0 | $0 | 0 | 1 | $0 |
| Aslam Shakil | Chief Medical Officer | 0 | $0 | 0 | 1 | $0 |
| Dasu Badri N | Chief Engineering Officer | 0 | $0 | 0 | 1 | $0 |